Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 639 (LINC00639) is a noncoding RNA gene located on chromosome 14q21.1, classified as a long intergenic non-coding RNA (lincRNA) and also annotated as a long non-coding RNA (lncRNA)[5][7]. LINC00639 does not encode a protein and is instead thought to regulate gene expression through RNA-based mechanisms, possibly involving chromatin remodeling, transcriptional regulation, RNA stabilization, and/or acting as a competing endogenous RNA (ceRNA)[3][4][10]. While LINC00639 itself has limited functional characterization, some context-specific data suggest roles in cancer via ceRNA networks[4], which is consistent with behaviors observed in the broader lincRNA family, such as tissue-specific regulation and potential as disease biomarkers[3][10]. As of now, there are no approved drugs or targeted therapeutics known to interact with LINC00639, and it is not established as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 639 (LINC00639).